|
| Synthetic Blood International, Inc., (SYBD) is a cutting edge biomedical product development company specializing in creating innovative pharmaceuticals and medical devices in the fields of liquid ventilation, oxygen therapeutics, blood substitutes, and implanted glucose sensing. Once these sophisticated products reach the market, they promise to revolutionize treatment of such disease states as diabetes, acute respiratory distress syndrome, stroke, myocardial infarction, and many malignant tumors. |
|
|
|
|
|
|
|
|
|
|
